• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT NAVION; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT NAVION; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VNMC4034C200TU
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Death (1802); Perforation (2001); Blood Loss (2597)
Date of Event 09/21/2020
Type of Reportable Event Death
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
A valiant navion stent graft system was implanted for the endovascular treatment of a thoracic dissection.The dissection measured from the lsa to iliac bifurcations.It was reported approximately 4 months post the index procedure, follow up ct demonstrated that the graft was distal to the lcca and had a type ia endoleak.During the initial procedure the graft appeared to be 5mm distal to the lcca and the final angiogram confirmed seal and the decision was made not to extend at that time however now the graft appears to have migrated distal leading to a type ia endoleak.The patient underwent aortic arch debranching and endograft placement from the ascending aorta into the existing descending thoracic graft.Vnmc4034c200tu (b)(4) was used.It was then reported one day later the patient started bleeding out of the mediastinal tube.The patient was rushed to the operating room and opened where it was noted that the proximal end of the graft had perforated the aorta.Multiple repair stitches were placed but would not hold in the fragile aorta and the patient continued to suffer blood loss and expired.Per the physician the cause of the migration was user error.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT NAVION
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
IE 
MDR Report Key10676705
Report Number9612164-2020-03910
Device Sequence Number14229417
Product Code MIH
UDI-Device Identifier00763000261047
UDI-Public00763000261047
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P100040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Operator of Device Health Professional
Device Expiration Date08/29/2022
Device Model NumberVNMC4034C200TU
Device Catalogue NumberVNMC4034C200TU
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/21/2020
Initial Report FDA Received Date10/14/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Death; Required Intervention;
Patient Age58 YR
-
-